Web Exclusives

How can pharma protect itself from cyber criminals?

Infusing automation into pharmacovigilance for COVID-19 treatments

Med affairs will need to take an increasingly significant role when it comes to engaging with patients and HCPs to unlock the full potential of healthcare, and creativity is the key

Five golden rules for pharma businesses to power sales from digital and e-commerce platforms

In the clinical trials race, there is no finish line

Research on early cancer detection has been hamstrung by market failure. We’ve got a plan to fix it.

How society’s changing relationship with health will break down the wall between pharma brands and consumers

How artificial intelligence can help pharma companies reach new audiences

And why does it matter more than ever following COVID-19?

Why the hybrid model is the way forward for live shows

Three ways to optimise energy consumption in pharma manufacturing

What does pharma have left to fight for in an EU trade deal?

How behavioural science can revolutionise training in the pharma industry

Identifying and stopping COVID-19 co-infections with broader diagnostics

How pharma can move digitalisation from theory to commercial reality